TD-9855: Clinical Trials

3 trials of TD-9855, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow TD-9855: new trials by email Literature Review of TD-9855 trials Research Report on TD-9855

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855
Ampreloxetine - Symptomatic Neurogenic Orthostatic Hypertension, nOH
Phase 1CompletedTheravance Biopharma312020-01-132021-09-08
Drug-Drug Interaction (DDI) Study for TD-9855
TD-9855, Fluvoxamine, Itraconazole - Drug Drug Interaction (DDI)
Phase 1CompletedTheravance Biopharma412018-02-282021-01-14
TD-9855 Mass Balance Study
TD-9855 - ADHD, Fibromyalgia
Phase 1CompletedTheravance Biopharma62013-10-012021-01-19

Conditions studied

Attention Deficit Disorder with Hyperactivity (1)  ·  Fibromyalgia (1)  ·  Smoking (1)

Sponsors

Theravance Biopharma (3)

Countries

United States (3)

Results publications

PMID 38654484